Literature DB >> 29491127

Bortezomib for prevention of acute graft-versus-host disease: a conclusion reached.

Paul J Martin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29491127      PMCID： PMC5830384          DOI： 10.3324/haematol.2018.188052

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

1.  Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.

Authors:  Marcelo C Pasquini; Brent Logan; Richard J Jones; Amin M Alousi; Frederick R Appelbaum; Javier Bolaños-Meade; Mary E D Flowers; Sergio Giralt; Mary M Horowitz; David Jacobsohn; John Koreth; John E Levine; Leo Luznik; Richard Maziarz; Adam Mendizabal; Steven Pavletic; Miguel-Angel Perales; David Porter; Ran Reshef; Daniel Weisdorf; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2018-01-08       Impact factor: 5.742

2.  Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.

Authors:  John Koreth; Kristen E Stevenson; Haesook T Kim; Michael Garcia; Vincent T Ho; Philippe Armand; Corey Cutler; Jerome Ritz; Joseph H Antin; Robert J Soiffer; Edwin P Alyea
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

Review 3.  Effects of bortezomib on the immune system: a focus on immune regulation.

Authors:  Mohamad Mohty; Eolia Brissot; Bipin N Savani; Beatrice Gaugler
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-22       Impact factor: 5.742

4.  Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.

Authors:  John Koreth; Kristen E Stevenson; Haesook T Kim; Sean M McDonough; Bhavjot Bindra; Philippe Armand; Vincent T Ho; Corey Cutler; Bruce R Blazar; Joseph H Antin; Robert J Soiffer; Jerome Ritz; Edwin P Alyea
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

5.  Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results.

Authors:  John Koreth; Haesook T Kim; Paulina B Lange; Samuel J Poryanda; Carol G Reynolds; Sharmila Chamling Rai; Philippe Armand; Corey S Cutler; Vincent T Ho; Brett Glotzbecker; Rushdia Yusuf; Sarah Nikiforow; Yi-Bin Chen; Bimalangshu Dey; Malgorzata McMasters; Jerome Ritz; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Edwin P Alyea
Journal:  Haematologica       Date:  2018-01-11       Impact factor: 9.941
  5 in total
  2 in total

Review 1.  Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation.

Authors:  Betty Ky Hamilton
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  An Overview of Autophagy in Hematopoietic Stem Cell Transplantation.

Authors:  Soheila Montazersaheb; Ali Ehsani; Ezzatollah Fathi; Raheleh Farahzadi; Ilja Vietor
Journal:  Front Bioeng Biotechnol       Date:  2022-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.